16 March 2018 EMA/CVMP/153976/2018 Committee for Medicinal Products for Veterinary Use
MRL summary opinion 1
Diflubenzuron Salmonidae
On 15 March 2018, the Committee for Medicinal Products for Veterinary Use (CVMP) adopted an opinion recommending the amendment of the entry for diflubenzuron in Table 1 (Allowed substances) of the Annex to Commission Regulation (EU) No 37/2010 in accordance with the following table: Pharmaco-
Marker
Animal
logically
residue
species
Diflubenzuron
Salmonidae
MRLs
Target
Other
Therapeutic
tissues
provisions
classification
Muscle and
NO ENTRY
Antiparasitic
active substance Diflubenzuron
10 µg/kg
skin in natural
agents / Agents
proportions
against ectoparasites
1
Summaries of opinion are published without prejudice to the Commission Decision.
30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact
Diflubenzuron - Summary opinion of the CVMP on the establishment ...
Mar 15, 2018 - 30 Churchill Place â Canary Wharf â London E14 5EU â United Kingdom. An agency of the European Union ... Animal species. MRLs. Target tissues. Other provisions. Therapeutic classification. Diflubenzuron Diflubenzuron. Salmonidae. 10 µg/kg Muscle and skin in natural proportions. NO ENTRY.
